STF Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$371K Sell
548
-654
-54% -$445K 0.35% 57
2025
Q3
$768K Sell
1,202
-38
-3% -$23.1K 0.28% 69
2025
Q2
$665K Buy
1,240
+16
+1% +$7.65K 0.26% 73
2025
Q1
$514K Sell
1,224
-20
-2% -$8.68K 0.25% 85
2024
Q4
$514K Buy
1,244
+60
+5% +$26.3K 0.23% 88
2024
Q3
$598K Sell
1,184
-168
-12% -$81.6K 0.27% 73
2024
Q2
$659K Sell
1,352
-63
-4% -$31.6K 0.28% 71
2024
Q1
$764K Buy
1,415
+1
+0.1% +$546 0.33% 67
2023
Q4
$785K Buy
1,414
+63
+5% +$29.6K 0.37% 64
2023
Q3
$591K Buy
1,351
+840
+164% +$419K 0.31% 74
2023
Q2
$257K Sell
511
-435
-46% -$208K 0.28% 71
2023
Q1
$473K Buy
946
+392
+71% +$188K 0.32% 67
2022
Q4
$226K Buy
+554
New +$215K 0.32% 71

Other funds holding IDXX

STF Management's IDXX Position: Q4 2025 in Review

STF Management reduced its Idexx Laboratories (IDXX) stake by 54% in Q4 2025, selling an estimated $445K and leaving 548 shares worth $371K. The position accounts for 0.35% of the portfolio, ranked #57.

STF Management first reported a position in IDXX in Q4 2022 and has held it in 13 quarters since. The position peaked at $785K in Q4 2023. 1,385 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • STF Management held 548 shares of Idexx Laboratories worth $371K as of Q4 2025.
  • STF Management sold 654 Idexx Laboratories shares in Q4 2025, an estimated $445K.
  • Idexx Laboratories made up 0.35% of STF Management's portfolio in Q4 2025, its #57 holding.
  • STF Management first reported a position in Idexx Laboratories in Q4 2022 and has held it in 13 quarters since.
  • STF Management's Idexx Laboratories position peaked at $785K in Q4 2023.
  • 1,385 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on STF Management's 13F filing for Q4 2025, filed 5 Feb 2026.